chitosan has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Hady, BM; Ekram, B; Okasha, H; Rashdan, HRM; Salem, MM | 1 |
| Abdelbary, A; Elshafeey, AH; Fatouh, AM | 1 |
2 other study(ies) available for chitosan and Chronic Hepatitis C
| Article | Year |
|---|---|
Investigation of novel HCV therapies: Boscia angustifalia & Boscia senegalensis extracts loaded on galactosylated chitosan nanoparticles synthesized by eco-friendly method for HCV treatment.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chitosan; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Nanoparticles | 2023 |
Liver targeting of ledipasvir via galactosylated chitosan-coated spanlastics: chemical synthesis, statistical optimization, in vitro, and pharmacokinetic evaluation.
Topics: Antiviral Agents; Benzimidazoles; Chitosan; Drug Carriers; Fluorenes; Hepatitis C, Chronic; Humans | 2022 |